Dyne Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
DYN
CUSIP
26818M108
Type
Equity
Class
COM
Num filings
204
Total reported value, excl. options
$3.97 B
Manager Report Date Value ($000) Shares Option Type